COVID-19 and Mycobacterium Tuberculosis Coinfection: A Case Report
A A Agada1, V Kwaghe1, Z Habib1
1Department of Internal Medicine, University of Abuja Teaching Hospital (UATH) Abuja, Nigeria.
This case study details a Nigerian man who survived coinfection with COVID-19 and tuberculosis. Early diagnosis and integrated treatment were key to his recovery from this dual infectious disease challenge.
Area of Science:
- Infectious Diseases
- Public Health
- Global Health
Background:
- COVID-19 pandemic presents significant global health challenges.
- Tuberculosis remains a leading cause of infectious disease mortality worldwide.
- Coinfection of COVID-19 and tuberculosis has not been previously documented.
Observation:
- A middle-aged Nigerian man presented with symptoms of COVID-19.
- Laboratory investigations confirmed coinfection with Mycobacterium tuberculosis.
- The patient received treatment for both COVID-19 and tuberculosis.
Findings:
- The patient successfully survived the coinfection.
- Integrated management including anti-tuberculous medications and supportive COVID-19 care was administered.
- Nutritional support played a role in recovery.
Implications:
- This case highlights the possibility of coexisting COVID-19 and tuberculosis.
- Effective management strategies are crucial for favorable outcomes in low-resource settings.
- Prompt diagnosis and combined treatment are vital for survival.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
